Pine Walk Capital Limited
Addresses
The contact details this firm has registered with the FCA.
-
Principal Place of Business
22 BishopsgateLevel 42LondonEC2N 4BQUNITED KINGDOM- Phone
- +442035748388
-
Complaints Contact
22 BishopsgateLevel 42LondonEC2N 4BQUNITED KINGDOM- Phone
- +4407353106334
What this firm is allowed to do
The regulated activities the FCA has granted this firm permission to carry out.
-
Investment Advice (no pensions)
For Commercial, Non-investment insurance contracts
-
Authorised to Operate
-
Arranges Investments
For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts
-
Insurance Admin
For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts
-
Stockbroking
For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts
-
Investment Setup
For Commercial, Retail (Non-Investment Insurance), Non-investment insurance contracts
Approved individuals
Senior staff personally approved by the FCA to hold their roles here.
-
Alexander John Rossiter
IRN AXR00870
- CF1 Director (AR) (10 Jan 2024 to 13 May 2025)
-
Andrew Robert Ray
IRN ARR01052
- CF1 Director (AR) (since 3 Jun 2024)
- CF3 Chief Executive (AR) (since 3 Jun 2024)
- SMF1 (AR) Chief Executive function (26 May 2022 to 3 Jun 2024)
- SMF3 (AR) Executive Director function (26 May 2022 to 3 Jun 2024)
-
Armin Rothauser
IRN AXR00814
- CF2 Non Executive Director (AR) (since 30 Oct 2023)
-
Caroline Lucy Coulson
IRN CXC00823
- CF1 Director (AR) (since 22 Jul 2024)
-
Charles Mathias
IRN CXM01803
- Responsible for Insurance Distribution (since 18 Jul 2025)
- SMF10 Chair of the Risk Committee (since 5 Apr 2024)
- SMF9 Chair of the Governing Body (since 23 Feb 2023)
-
Christopher Smith Sweetser
IRN CSS01070
- SMF11 Chair of the Audit Committee (since 26 Aug 2025)
- SMF4 Chief Risk (1 Mar 2024 to 19 Sep 2025)
-
Clive Andrew Washbourn
IRN CAW01109
- CF1 Director (AR) (since 3 Jun 2024)
- CF3 Chief Executive (AR) (since 3 Jun 2024)
- SMF1 (AR) Chief Executive function (10 Mar 2022 to 3 Jun 2024)
- SMF3 (AR) Executive Director function (10 Mar 2022 to 3 Jun 2024)
-
Conor O'Riordan
IRN CXO00032
- CF1 Director (AR) (26 Aug 2025 to 27 Apr 2026)
- CF2 Non Executive Director (AR) (14 Sep 2023 to 27 Apr 2026)
-
Daniel Robert Mereu
IRN DXM01143
- CF1 Director (AR) (since 14 Mar 2025)
-
David James Daniel Woods
IRN DXW00751
- CF1 Director (AR) (since 10 Feb 2025)
Appointed representatives
Smaller firms operating under this firm's FCA authorisation.
-
CARNOVIS SPECIALTY LIMITED
FRN 1042554 · Appointed 14 Oct 2025
-
ARENITE SPECIALTY LIMITED
FRN 1038390 · Appointed 29 Aug 2025
-
CORSIAM SPECIALTY LIMITED
FRN 1038971 · Appointed 26 Aug 2025
-
SEVANTA SPECIALTY LIABILITY LIMITED
FRN 1024552 · Appointed 10 Feb 2025
-
SILVERFLAME RE LIMITED
FRN 1018413 · Appointed 23 Sep 2024
-
SERAPHINA SPECIALTY LIMITED
FRN 1017394 · Appointed 16 Sep 2024
-
NOVAGEN SPECIALTY LIMITED
FRN 1015573 · Appointed 6 Aug 2024
-
Itasca MGA Limited
FRN 1000117 · Appointed 20 Jul 2023
-
Perigon Product Recall Limited
FRN 916176 · Appointed 2 Mar 2022
-
Navium Marine Limited
FRN 952242 · Appointed 2 Mar 2022
Recent activity
Updates to this firm's record on the FCA register.
No changes recorded yet.